Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725900 | SCV000340360 | pathogenic | not provided | 2016-03-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001855178 | SCV002229478 | pathogenic | Zellweger spectrum disorders | 2021-10-31 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 286796). This sequence change creates a premature translational stop signal (p.Asp378Metfs*9) in the PEX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX1 are known to be pathogenic (PMID: 9398847, 16086329, 16141001, 21031596, 26387595, 31831025). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with PEX1-related conditions. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV000725900 | SCV003927727 | likely pathogenic | not provided | 2022-11-28 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |
Counsyl | RCV000317622 | SCV000794955 | likely pathogenic | Peroxisome biogenesis disorder 1B | 2017-10-23 | no assertion criteria provided | clinical testing |